FDA Drug Label

Name: FDA Drug Label
Price: 0.003 USDC
Availability: InStock

Official FDA label of a drug by brand or generic name: indications, dosage, warnings, boxed warning, contraindications, adverse reactions, interactions, pharmacologic class, manufacturer and NDC codes.

MediaLiveeip155:8453Exactvia cdp

https://bess-x402.onrender.com/v1/health/drug-label

HealthDrugsFdaMedicinePharma

Settlements · 30d

420

No per-endpoint history for this service yet, so this is payments indexed to its PROVIDER's wallet over 30 days.

$1.55

Verified settled volume

420 settlements proven x402 by their on-chain EIP-3009 marker.

$0.0030

Listed price

As published in the catalog. Always read the live 402 before paying.

Calls · 30d

Upstream's own call count for this endpoint, not ours.

Unique payers · 30d

Last called 2026-10-26 10:33Z

—

Upstream on-chain volume

Reported by the source catalog.

Paid to

0x1129A6BB9C6165FF07fdC509c107B522CA0e1871

The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.

Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913

Provider

The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.

Accepts

The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.

0.003USDC≈ $0.003 USD

on Base · exact scheme

Pay 0.003 USDC on Base to 0x1129…e1871. The signed payment is good for 5 minutes.

Paid to: 0x1129…e1871
USD Coin contract: 0x8335…02913
Payment window: 5 minutes
As published: 3000 smallest units

3000units

on Polygon · exact scheme

That figure is in the token’s smallest units. Roundhouse does not hold this contract’s decimals, so it is shown as published rather than converted.

Paid to: 0x1129…e1871
Token contract: 0x3c49…c3359
Payment window: 5 minutes

3000units

on Arbitrum · exact scheme

That figure is in the token’s smallest units. Roundhouse does not hold this contract’s decimals, so it is shown as published rather than converted.

Paid to: 0x1129…e1871
Token contract: 0xaf88…e5831
Payment window: 5 minutes

The catalog’s raw entry

[
  {
    "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
    "extra": {
      "name": "USD Coin",
      "version": "2"
    },
    "payTo": "0x1129A6BB9C6165FF07fdC509c107B522CA0e1871",
    "amount": "3000",
    "scheme": "exact",
    "network": "eip155:8453",
    "maxTimeoutSeconds": 300
  },
  {
    "asset": "0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359",
    "extra": {
      "name": "USD Coin",
      "version": "2"
    },
    "payTo": "0x1129A6BB9C6165FF07fdC509c107B522CA0e1871",
    "amount": "3000",
    "scheme": "exact",
    "network": "eip155:137",
    "maxTimeoutSeconds": 300
  },
  {
    "asset": "0xaf88d065e77c8cC2239327C5EDb3A432268e5831",
    "extra": {
      "name": "USD Coin",
      "version": "2"
    },
    "payTo": "0x1129A6BB9C6165FF07fdC509c107B522CA0e1871",
    "amount": "3000",
    "scheme": "exact",
    "network": "eip155:42161",
    "maxTimeoutSeconds": 300
  }
]

Extensions

{
  "bazaar": {
    "info": {
      "input": {
        "type": "http",
        "method": "GET",
        "queryParams": {
          "name": "metformin",
          "limit": 1
        }
      },
      "output": {
        "type": "json",
        "example": {
          "note": "Official FDA label text for information only, not medical advice.",
          "count": 1,
          "query": "metformin",
          "labels": [
            {
              "ndc": [
                "70771-1859",
                "70771-1860"
              ],
              "route": [
                "ORAL"
              ],
              "rxcui": [
                "861769",
                "861819"
              ],
              "set_id": "0098dec4-f0e5-45d5-8aa4-5d0faf9ab142",
              "pregnancy": "8.1 Pregnancy Risk Summary Available data with ZITUVIMET and sitagliptin use in pregnant women are not sufficient to inform a ZITUVIMET-associated or sitagliptin-associated risk for major birth defects and miscarriage. Published studies with metformin use during pregnancy have not reported a clear a...",
              "brand_name": "ZITUVIMET",
              "label_date": "2026-08-12",
              "substances": [
                "SITAGLIPTIN",
                "METFORMIN HYDROCHLORIDE"
              ],
              "pharm_class": [
                "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
                "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
              ],
              "generic_name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
              "manufacturer": "Zydus Lifesciences Limited",
              "product_type": "HUMAN PRESCRIPTION DRUG",
              "boxed_warning": "WARNING: LACTIC ACIDOSIS WARNING: LACTIC ACIDOSIS See full prescribing information for complete boxed warning . Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respirato...",
              "adverse_reactions": "6 ADVERSE REACTIONS The following adverse reactions are also discussed elsewhere in the prescribing information: Lactic Acidosis [see Warnings and Precautions ( 5.1 )] Pancreatitis [see Warnings and Precautions ( 5.2 )] Heart Failure [see Warnings and Precautions ( 5.3 )] Acute Renal Failure [see Wa...",
              "contraindications": "4 CONTRAINDICATIONS Severe renal impairment: (eGFR below 30 mL/min/1.73 m 2 ) ( 4) Metabolic acidosis, including diabetic ketoacidosis. ( 4 ) History of a serious hypersensitivity reaction to ZITUVIMET, sitagliptin, or metformin, such as anaphylaxis or angioedema. (4) ZITUVIMET is contraindicated in...",
              "drug_interactions": "7 DRUG INTERACTIONS Table 4 presents clinically significant drug interactions with ZITUVIMET: Table 4: Clinically Significant Drug Interactions with ZITUVIMET Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-...",
              "application_number": "NDA216743",
              "indications_and_usage": "1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Z...",
              "dosage_and_administration": "2 DOSAGE AND ADMINISTRATION Take ZITUVIMET orally twice daily with meals. ( 2.1 ) Individualize the dosage of ZITUVIMET on the basis of the patient's current regimen, effectiveness, and tolerability. ( 2.1 ) The maximum recommended daily dose is 100 mg of sitagliptin and 2,000 mg of metformin HCl. (..."
            }
          ],
          "source": "openFDA drug labels (CC0)"
        }
      }
    },
    "schema": {
      "type": "object",
      "$schema": "https://json-schema.org/draft/2020-12/schema",
      "required": [
        "input"
      ],
      "properties": {
        "input": {
          "type": "object",
          "required": [
            "type",
            "method"
          ],
          "properties": {
            "type": {
              "type": "string",
              "const": "http"
            },
            "method": {
              "enum": [
                "GET",
                "HEAD",
                "DELETE"
              ],
              "type": "string"
            },
            "queryParams": {
              "type": "object",
              "required": [
                "name"
              ],
              "properties": {
                "name": {
                  "type": "string",
                  "description": "Brand or generic name, e.g. Ozempic or metformin"
                },
                "limit": {
                  "type": "integer",
                  "description": "Labels (1-10)"
                }
              }
            }
          },
          "additionalProperties": false
        },
        "output": {
          "type": "object",
          "required": [
            "type"
          ],
          "properties": {
            "type": {
              "type": "string"
            },
            "example": {
              "type": "object"
            }
          }
        }
      }
    }
  }
}

Provenance

Seen in the source catalog: 2026-10-26 10:33Z
Last indexed by Roundhouse: 2026-10-26 22:50Z
Last enriched (probe, favicon, geo): 2026-10-26 12:46Z
x402 version: 2
Max timeout: 300s
Liveness probe: HTTP 402

Report

Hand this page to an agent

Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.

GET api.roundhouseai.io/v0/endpoints

No per-endpoint history for this service yet, so this is payments indexed to its PROVIDER's wallet over 30 days. Verified volume counts only settlements with an on-chain EIP-3009 marker.

Open skill.md

Show the prompt

Using Roundhouse, look up the x402 service FDA Drug Label and tell me whether it is
worth paying: what a call costs, whether the endpoint answered when last probed, and what
its payment record actually shows.

curl -s 'https://api.roundhouseai.io/v0/endpoints?q=FDA%20Drug%20Label'
curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>'

Then call it: read the price from the live 402 at https://bess-x402.onrender.com/v1/health/drug-label, never from
a cached figure, and pay with an x402 client.

The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except
/v0/unified* and /v0/endpoints. Either pay over x402 (mint a personal key for $0.01 at
GET https://api.roundhouseai.io/v0/test/x402), or ask me for an organization key, which I create at
https://roundhouseai.io/dashboard/connections. If you have neither, ask before going further.

If you do not have Roundhouse tools or skills installed, read
https://roundhouseai.io/skill.md first — it is the whole procedure.